pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
onabotulinumtoxinA
Botox (onabotulinumtoxinA)
Lower Limb Muscle Spasticity
Allergan Sales LLC
0 catalysts
Preclinical
onabotulinumtoxinA biosimilar
Blepharospasm
$VTRSViatris Inc
0 catalysts
Marketed
onasemnogene abeparvovec
Itvisma (onasemnogene abeparvovec-xioi)
Spinal Muscular Atrophy (SMA)
Novartis Gene Therapies
0 catalysts
← prev
page 202 of 231
next →
131
Pain89
Neurology1
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
0 catalysts
Phase 2
onrogadgene parvec
Parkinson's Disease
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 2
ontunisertib
Crohn's Disease (Regional Enteritis)
$AGMBAgomab Therapeutics NV
0 catalysts
Phase 2
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDFCardiff Oncology, Inc.
0 catalysts
Phase 2
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
0 catalysts
Phase 3
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
ADARx Pharmaceuticals Inc
0 catalysts
Phase 2
onzemipgene parvec
onzemipgene parvec [INN]
Dry (Atrophic) Macular Degeneration
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHLRedHill Biopharma Ltd.
0 catalysts
Phase 3
opiranserin
opiranserin [INN]
Post-Operative Pain
Vivozon Inc
0 catalysts
Phase 2
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBXInhibrx Biosciences, Inc.
0 catalysts
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
Mucin-16
OncoQuest Inc
0 catalysts
Phase 3
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 2
orismilast
orismilast [INN]
Plaque Psoriasis (Psoriasis Vulgaris)
Union Therapeutics AS
0 catalysts
Marketed
oritavancin diphosphate
Orbactiv (oritavancin diphosphate)
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
A. Menarini Industrie Farmaceutiche Riunite Srl
0 catalysts
Marketed
orlistat
Xenical (orlistat)
Obesity
H2-Pharma LLC
0 catalysts
Marketed
orphenadrine citrate ER
Orphenadrine Citrate (orphenadrine citrate)
Musculoskeletal Pain
Lupin Research Inc
0 catalysts
Phase 2
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
orvepitant
Chronic Cough
Substance-P receptor
NeRRe Therapeutics Ltd
0 catalysts
Phase 2
orziloben
Liver Diseases
NorthSea Therapeutics BV
0 catalysts
Phase 2
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
0 catalysts
Marketed
osimertinib mesylate
Tagrisso (osimertinib mesylate)
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
$AZNASTRAZENECA PLC
0 catalysts
Phase 3
osivelotor
Sickle Cell Disease
$PFEPFIZER INC
0 catalysts
Marketed
ospemifene
Osphena (ospemifene)
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy)
Duchesnay USA Inc
0 catalysts
Marketed
oteseconazole
Vivjoa (oteseconazole)
Onychomycosis (Tinea Unguium)
Lanosterol 14-alpha demethylase
Mycovia Pharmaceuticals Inc
0 catalysts
pre_registration
oveporexton
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Marketed
oxacillin
Bactocill (oxacillin [INN])
Staphylococcal Infections
Baxter Healthcare Corp
0 catalysts
Marketed
oxacillin sodium
Oxacillin Sodium (oxacillin sodium)
Abscess
Eugia US LLC
0 catalysts